All Primary Antibodies
Primary antibodies, immunoglobulins that bind to specific proteins or other biomolecules, are used in many research applications and protocols to detect targets of interest. They are developed using different animal hosts, including mouse, rat, rabbit, goat, sheep, and many others.
Monoclonal and Polyclonal Antibodies
One type of primary antibodies, monoclonal antibodies, provides high reproducibility and low cross-reactivity and background noise. Another type, polyclonal antibodies, often costs less and provides greater affinity and quicker binding. Both are produced using plasma B cells, but the former uses the same clone and the latter uses different clones. Monoclonal antibodies require hybridoma cell lines, and polyclonal antibodies do not.
There are also recombinant monoclonal antibodies with similar benefits, like high affinity, scalability, and specificity. They are produced using in vitro cloning of plasma B cells and expression hosts.
Conjugated Primary Antibodies
Antibodies can be labeled with various fluorophores or detection agents or used without labels. Labeled primary antibodies, also known as conjugated primary antibodies, help researchers simplify and streamline their applications. They are coupled with common enzymes and dyes such as Alexa Fluor and often used in protein and cell analysis.
Applications
Antibodies for life sciences applications are used in flow cytometry, western blotting, ELISA, immunohistochemistry, and immunocytochemistry. Secondary antibodies can be added to support the detection and purification of certain antigens. They bind to the primary antibody, which binds to the antigen of interest. Finding the right combination of antibodies can result in greater antigen specificity and a strong, detectable signal.
- (1)
- (24)
- (11)
- (2)
- (2)
- (3)
- (3)
- (2)
- (1,588)
- (8)
- (4)
- (44)
- (225)
- (10)
- (4)
- (13)
- (68)
- (42,636)
- (2)
- (85,800)
- (17,755)
- (21)
- (283)
- (56)
- (898)
- (1)
- (8)
- (260)
- (1)
- (2)
- (1)
- (40)
- (23)
- (2)
- (1)
- (4)
- (12)
- (1)
- (1,592)
Résultats de la recherche filtrée
CHD4 Recombinant Human Monoclonal Antibody (K49015_15E2), Invitrogen™
Human Recombinant Monoclonal Antibody
| Applications | ELISA,Western Blot |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 |
| Conjugué | Unconjugated |
| Espèces cibles | Human |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| Forme | Liquid |
| État réglementaire | RUO |
| Numéro d’ordre du gène | Q14839 |
| Immunogène | Recombinant human CHD4 (immunogen range is 1291-1550). |
| Expression | CHD4 |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 1108 |
| Méthode de purification | Protein A |
| Espèces hôtes | Human |
| Formule | PBS with 50% glycerol, 0.5% BSA and 0.09% sodium azide |
| Alias de gène | 9530019N15Rik; AA617397; ATP-dependent helicase CHD4; BC005710; Chd4; CHD-4; chromodomain helicase DNA binding protein 4; chromodomain-helicase-DNA-binding protein 4; D6Ertd380e; Mi-2; Mi-2 autoantigen; Mi-2 autoantigen 218 kDa protein; Mi-2 beta; MI2B; Mi-2b; Mi-2beta; Mi2-BETA; mKIAA4075 |
| Clone | K49015_15E2 |
| Antigène | CHD4 |
CD20 Monoclonal Antibody (2H7), Brilliant Ultra Violet™ 395, eBioscience™, Invitrogen™
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Mouse Monoclonal Antibody
| Applications | Flow Cytometry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2b κ |
| Conjugué | Brilliant Ultraviolet 395 |
| Espèces cibles | Human |
| Concentration | 5 μL/Test |
| Primaire ou secondaire | Primary |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| Forme | Liquid |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P11836 |
| Expression | Ms4a1 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 931 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Formule | PBS with BSA and 0.09% sodium azide; pH 7.2 |
| Alias de gène | AA960661; APY; ATOPY; B1; B-cell differentiation antigen Ly-44; B-lymphocyte antigen CD20; B-lymphocyte cell-surface antigen B1; B-lymphocyte surface antigen B1; Bp35; Cd20; CD20 antigen; CD20 cell surface protein; CD20 receptor; CVID5; EGK_06167; Fc epsilon receptor I beta chain; Fc Fragment of IgE high affinity I receptor for beta polypeptide; FCER1B; High affinity immunoglobulin epsilon receptor subunit beta; IgE Fc receptor subunit beta; IGEL; IGER; IGHER; LEU16; LEU-16; Leukocyte surface antigen Leu-16; Ly44; Ly-44; Lymphocyte antigen 44; membrane spanning 4-domains A1; membrane-spanning 4-domains subfamily A member 1; membrane-spanning 4-domains, subfamily A, member 1; membrane-spanning 4-domains, subfamily A, member 2; MGC3969; MS4A1; MS4A2; S7 |
| Clone | 2H7 |
| Antigène | CD20 |
Epredia™ Lab Vision™ CD71/Transferrin Receptor Ab-3, Mouse Monoclonal Antibody
Ensure accurate, reproducible results in immunohistochemistry applications with Epredia™ CD71/Transferrin Receptor Ab-3, Mouse Monoclonal Antibody.
| État réglementaire | RUO |
|---|---|
| Applications | Immunohistochemistry (Paraffin) |
| Classification | Monoclonal |
| Isotype | IgG2b |
| Conjugué | Unconjugated |
| Espèces cibles | Human |
| Espèces hôtes | Mouse |
| Primaire ou secondaire | Primary |
| Clone | 10F11 |
| Antigène | CD71/Transferrin Receptor Ab-3 |
MHC II (HLA-DR) Ab-1 Mouse Monoclonal Antibody, Epredia™
Epredia™ MHC II (HLA-DR) Ab-1, Mouse Monoclonal Antibody provides accurate, reproducible results.
| État réglementaire | RUO |
|---|---|
| Immunogène | Activated human peripheral blood mononuclear cells |
| Applications | Flow Cytometry,Immunohistochemistry (Paraffin) |
| Classification | Monoclonal |
| Isotype | IgG2b |
| Conjugué | Unconjugated |
| Espèces cibles | Human |
| Disciplines de recherche | Hematopoietic |
| Espèces hôtes | Mouse |
| Primaire ou secondaire | Primary |
| Forme | Concentrated |
| Clone | LN3 |
| Antigène | MHC II (HLA-DR) Ab-1 |
Progesterone Receptor Ab-6 Mouse Monoclonal Antibody, Epredia™
Provide accurate, reproducible results with the Epredia™ Progesterone Receptor Ab-6, Mouse Monoclonal Antibody.
| État réglementaire | RUO |
|---|---|
| Immunogène | Partially purified PgR from a human endometrial carcinoma (EnCa 101) grown in athymic mice |
| Applications | Immunofluorescence,Immunoprecipitation |
| Classification | Monoclonal |
| Isotype | IgG2b |
| Conjugué | Unconjugated |
| Espèces cibles | Bovine,Chicken,Human,Rabbit |
| Disciplines de recherche | Cancer and Tumor Biology |
| Espèces hôtes | Mouse |
| Primaire ou secondaire | Primary |
| Forme | Concentrated |
| Clone | hPRa 6 |
| Antigène | Progesterone Receptor Ab-6 |
Invitrogen™ H3K27me2 Polyclonal Antibody
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Rabbit Polyclonal Antibody
| Applications | Immunocytochemistry,Western Blot |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG |
| Conjugué | Unconjugated |
| Espèces cibles | Human |
| Concentration | 0.5 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P68431, Q71DI3 |
| Immunogène | Peptide corresponding to Human HIST1H3A (aa 24-31). |
| Expression | H3C15 |
| Classification | Polyclonal |
| Identification génétique (Entrez) | 126961, 333932, 8350, 8356, 8357, 8358, 8968 |
| Méthode de purification | Affinity Chromatography |
| Espèces hôtes | Rabbit |
| Symboles de gène(s) | H3C1, H3C10, H3C12, H3C14, H3C15, H3C2, H3C7 |
| Formule | PBS with 0.1% BSA, 30% glycerol and 0.09% sodium azide; pH 7.2 |
| Alias de gène | dimethyl H3; di-methyl H3; Dimethyl Histone H3; di-methyl histone H3; Di-Methyl-H3 K27; Di-Methyl-H3 Lys27; Di-Methyl-Histone H3 K27; Di-Methyl-Histone H3 Lys27; Di-Tri-Methyl-Histone H3 K27; Di-Tri-Methyl-Histone H3 Lys27; H3; H3 histone; H3 histone family, member A; H3 histone family, member I; H3 histone family, member K; H3 histone family, member L; H3 histone family, member M; H3 histone, family 2; H3 histone, family 3A; H3 histone, family 3B; H3 histone, family 3B (H3.3B); H3 histone, family 3B.1; H3 histone, family 3C; H3 K27me2; H3.1-221; H3.1-291; H3.1-I; H3.2; H3.2-221; H3.2-614; H3.2-615; H3.2-616; H3.3A; H3.3B; H3.5; H3/A; H3/b; H3/d; H3/f; H3/i; H3/j; H3/k; H3/l; H3/M; H3/n; H3/o; H3-143; H3-291; H3-3A; H3-3B; h3-5; H3-53; H3-614; H3a; H3b; H3-B; H3C1; H3c10; H3c11; H3C12; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3f; H3-F; H3F1K; H3F2; H3F3; h3f3a; H3F3B; h3f3b.1; h3f3c; h3f3d; H3FA; H3FB; H3FC HIST1H3C; H3FD; H3FF; H3FH; H3FI; H3FJ; H3FK; H3FL; H3FM; H3FN; H3g; H3h; H3i; H3k27; H3K27me2/3; H3K27me2me3; H3Lys27me2; H3Lys27me2/3; H3Lys27me2me3; Hist1; HIST1H3A; HIST1H3B; Hist1h3c; HIST1H3D; Hist1h3e; HIST1H3F; Hist1h3g; HIST1H3H; HIST1H3I; HIST1H3J; HIST2H3A; Hist2h3b; HIST2H3C; Hist2h3c1; Hist2h3c2; Hist2h3c2-ps; Hist2h3ca1; Hist2h3ca2; HIST2H3D; histone 1, H3a; histone 1, H3b; histone 1, H3f; histone 1, H3h; histone 2, H3a; histone 2, H3c; histone 2, H3c2; histone 2, H3ca2; Histone 3; histone cluster 1, H3a; histone cluster 1, H3b; histone cluster 1, H3f; histone cluster 1, H3h; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3c2; histone cluster 2, H3c2, pseudogene; histone gene complex 1; histone H3; histone H3.1; Histone H3.2; histone H3.3; Histone H3.3C; histone H3.5; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; histone H3/l; Histone H3/m; histone H3/o; Histone H3K27; Histone H3K27me2; histone variant H3.5; hypothetical protein LOC550262; M32461; methyl Histone 3; methyl Histone H3; PP781; wu:fa25h06; wu:fa96g06; wu:fb07a08; wu:fb36f01; zgc:110292; zgc:174300; zgc:56193; zgc:56418; zgc:64222; zgc:86731 |
| Antigène | H3K27me2 |
CIRBP Mouse anti-Human, Clone:6E12B3, Abnova™
Mouse monoclonal antibody raised against recombinant human CIRBP.
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | Alexa Fluor 700 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P34810 |
| Expression | Cd68 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 968 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | Cd68 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | CD68; CD68 antigen; CD68 molecule; GP110; Lamp4; macrophage antigen CD68; macrosialin; Scard1; scavenger receptor class D, member 1; similar to CD68 antigen |
| Clone | KP1 |
| Antigène | CD68 |
Invitrogen™ CD107a (LAMP-1) Monoclonal Antibody (eBioH4A3), Alexa Fluor™ 700
Mouse Monoclonal Antibody
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | Alexa Fluor 700 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P11279 |
| Expression | LAMP1 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 3916 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | LAMP1 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | 120 kDa lysosomal membrane glycoprotein; AI196048; CD107 antigen-like family member A; CD107a; I79_011073; Lamp I; LAMP1; LAMP-1; LAMPA; LGP120; LGP-120; LGPA; LGP-A; lysosomal associated membrane protein 1; Lysosomal associated membrane protein 1 (120 kDa); lysosomal membrane glycoprotein 1; lysosomal membrane glycoprotein A; lysosomal-associated membrane protein 1; lysosome-associated membrane glycoprotein 1; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEIN 1 PRECURSOR (LAMP-1) (LGP-A) (LGP-120) (CD107A) (P2B); lysosome-associated membrane protein 1; P2B |
| Clone | eBioH4A3 |
| Antigène | CD107a (LAMP-1) |
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2b κ |
| Conjugué | Alexa Fluor 700 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P04637 |
| Immunogène | Recombinant human wild-type p53 protein expressed in E. coli. |
| Expression | Tp53 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 7157 |
| Méthode de purification | Protein A |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | Tp53 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | Antigen NY-CO-13; bbl; BCC7; bfy; bhy; cellular tumor antigen p53; Cys 51 Stop; EGK_08142; FLJ92943; HGNC11998; I79_002739; LFS1; Li-Fraumeni syndrome; mutant p53; mutant tumor protein 53; OTTMUSP00000006194; p44; p53; p53 cellular tumor antigen; p53 protein; p53 tumor suppressor; p53 tumor suppressor phosphoprotein; phosphoprotein p53; Tp53; tp53.L; transformation related protein 53; transformation-related protein 53; Trp248; Trp53; tumor protein 53; tumor protein p53; tumor protein p53 (Li-Fraumeni syndrome); tumor protein p53 L homeolog; tumor suppressor p53; tumor suppressor p53 phosphoprotein; tumor suppressor protein p53; tumor supressor p53; Tumour Protein p53; XELAEV_180196761mg; Xp53; Xrel3 |
| Clone | DO-7 |
| Antigène | p53 |
Invitrogen™ Pan Cytokeratin Monoclonal Antibody (AE1/AE3), Alexa Fluor™ 700
Mouse Monoclonal Antibody
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 |
| Conjugué | Alexa Fluor 700 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P02533, P02538, P04264, P05783, P05787, P08727, P08729, P08779, P12035, P13645, P13646, P13647, P19012, P19013, P35908, Q01546, Q04695, Q7Z794 |
| Expression | KRT19 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 374454, 3848, 3849, 3850, 3851, 3852, 3853, 3855, 3856, 3858, 3860, 3861, 3866, 3868, 3872, 3875, 3880, 51350 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | KRT1, KRT10, KRT13, KRT14, KRT15, KRT16, KRT17, KRT18, KRT19, KRT2, KRT3, KRT4, KRT5, Krt6a, KRT7, KRT76, KRT77, KRT8 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | 2310016L08Rik; 3300001P10Rik; 39.1; 40-kDa keratin intermediate filament; 47 kDa cytokeratin; 56 kDa cytokeratin; 57kd keratin; 57kDa keratin; 58 kDa cytokeratin; 60-kDa keratin; 63kDa Keratin; 65 kDa cytokeratin; 67 kDa cytokeratin; AA960620; adult keratin; AI324768; AI528832; AI626930; AI663979; AL022697; alpha keratin; AU019895; AW108092; AW146334; basic epidermal type II cytokeratin (carboxy-terminal region, clone pUF164); BB005427; BCIE; BIE; Card2; cell proliferation-inducing gene 46 protein; CK 2e; CK1; CK-1; CK10; CK-10; CK13; CK-13; CK14; CK-14; CK15; CK-15; CK16; CK-16; CK-17; CK18; CK-18; CK19; CK-19; CK-1B; CK-2e; CK3; CK-3; CK4; CK-4; CK5; CK-5; ck55; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; CK7; CK-7; CK8; CK-8; CYK18; CYK4; CYK8; CYKER; cytokeratin 1; cytokeratin 10; cytokeratin 13; cytokeratin 14; cytokeratin 15; cytokeratin 16; cytokeratin 18; cytokeratin 19; cytokeratin 3; cytokeratin 4; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin 7; cytokeratin 8; cytokeratin 8 (370 AA); cytokeratin endo A; Cytokeratin endo B; cytokeratin otokeratin; cytokeratin type II; cytokeratin type II, component Ib/c; cytokeratin type II, component III; cytokeratin VIB; cytokeratin VII; cytokeratin-1; Cytokeratin-10; cytokeratin-13; Cytokeratin-14; cytokeratin-15; Cytokeratin-16; cytokeratin-17; Cytokeratin-18; cytokeratin-19; Cytokeratin-1B; Cytokeratin-2e; cytokeratin-3; Cytokeratin-4; cytokeratin-5; Cytokeratin-6A; cytokeratin-6B; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; cytokeratin-7; Cytokeratin-8; cytokeratin-A; Cytoskeletal 57 kDa keratin; D130054E02Rik; D15Wsu77e; DDD; DDD1; ear specific cytokeratin; EBS2; ebs3; ebs4; EGK_03684; EGK_03685; EHK; EHK1; Endo B; EndoA; EndoC; epidermal keratin 10; epidermal keratin VII; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; epidermolysis bullosa simplex, Dowling-Meara, Koebner; epidermolytic hyperkeratosis 1; epidermolytic hyperkeratosis; keratosis palmaris et plantaris; epithelial keratin 1; epithelial keratin 10; epithelial keratin 2e; Epithelial keratin-1; Epithelial keratin-2e; EPPK; fgk; fin and gill keratin; FNEPPK; focal non-epidermolytic palmoplantar keratoderma; GK-19; Hair alpha protein; HMWCK; Hom s 5; I79_019823; I79_021074; I79_023185; I79_024335; intermediate filament protein; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1B; K1C1; K1CO; K1CP; K1CS; K2C7; K2C8; K2e; K3; K3 keratin; K4; K5; K6A; K6a keratin; K6C; K6D; K7; K77; K8; Ka10; Ka13; Ka14; Ka15; Ka16; Ka17; Ka19; kamp-keratin derived antimicrobial peptide; Kb1; Kb2; Kb4; Kb7; KDAMP; KER1; Ker10; Ker2; KERA; keratin; keratin 1; keratin 1 (epidermolytic hyperkeratosis); keratin 1, type II; keratin 10; keratin 10 (epidermolytic hyperkeratosis); keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris); keratin 10, type I; keratin 10, type I L homeolog; keratin 10, type I S homeolog; keratin 12, gene 2 S homeolog; keratin 13; keratin 13, type I; keratin 13, type I S homeolog; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 14, type I L homeolog; keratin 15; keratin 15, gene 1 S homeolog; keratin 15, type I; keratin 16; keratin 16 (focal non-epidermolytic palmoplantar keratoderma); keratin 16, type I; keratin 16, type I S homeolog; keratin 17; keratin 17 L homeolog; keratin 17, type I; keratin 17, type I L homeolog; keratin 18; keratin 18, type I; keratin 19; keratin 19 S homeolog; keratin 19 S homeolog; keratin 19; keratin 19, type I; Keratin 1B; keratin 2; keratin 2 (epidermal ichthyosis bullosa of Siemens); keratin 2 epidermis; keratin 2, type II; keratin 24; keratin 2A; keratin 2A (epidermal ichthyosis bullosa of Siemens); keratin 3; keratin 3, type II; keratin 4; keratin 4, type II; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) |
| Clone | AE1/AE3 |
| Antigène | Pan Cytokeratin |
Invitrogen™ Alpha-Smooth Muscle Actin Monoclonal Antibody (1A4), Alexa Fluor™ 700
Mouse Monoclonal Antibody
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2a κ |
| Conjugué | Alexa Fluor 700 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P62736 |
| Expression | ACTA2 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 59 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | ACTA2 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | 0610041G09Rik; AAT6; ACT-4; acta2; acta2.L; acta2.S; actin; Actin Alpha 2 Smooth Muscle Aorta; actin alpha 2, smooth muscle; Actin Vascular Smooth Muscle; actin, alpha 2, smooth muscle, aorta; actin, alpha 2, smooth muscle, aorta L homeolog; actin, alpha 2, smooth muscle, aorta S homeolog; actin, alpha, vascular smooth muscle; actin, aortic smooth muscle; Actin, aortic smooth muscle, intermediate form; ACTSA; ACTVS; alpha actin 2; Alpha Cardiac Actin; alpha smooth muscle actin; alpha-actin; Alpha-actin-2; alpha-cardiac actin; alphaSMA; alpha-SM-actin; alpha-smooth muscle actin; Aortic Smooth Muscle; asma; a-sma; cell growth-inhibiting gene 46 protein; GIG46; Growth Inhibiting Gene 46; hypothetical protein LOC515610; LOW QUALITY PROTEIN: actin, aortic smooth muscle; mymy5; SM actin; sma; SMactin; sm-actin; SMalphaA; smooth muscle; smooth muscle alpha-actin; vascular smooth muscle alpha-actin; wu:fb63d03; XELAEV_18034370mg |
| Clone | 1A4 |
| Antigène | Alpha-Smooth Muscle Actin |
CD4 Monoclonal Antibody (SK3 (SK-3)), NovaFluor™ Blue 725, eBioscience™, Invitrogen™
Mouse Monoclonal Antibody
| Applications | Flow Cytometry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | NovaFluor Blue 725 |
| Espèces cibles | Human |
| Concentration | 0.1 μg/Test |
| Primaire ou secondaire | Primary |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| Forme | Liquid |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P01730 |
| Expression | CD4 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 920 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Formule | PBS with BSA and 0.09% sodium azide; pH 7.2 |
| Alias de gène | Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen |
| Clone | SK3 (SK-3) |
| Antigène | CD4 |
CD4 Monoclonal Antibody (SK3 (SK-3)), NovaFluor™ Blue 800, eBioscience™, Invitrogen™
Mouse Monoclonal Antibody
| Applications | Flow Cytometry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | NovaFluor Blue 800 |
| Espèces cibles | Human |
| Concentration | 0.1 μg/Test |
| Primaire ou secondaire | Primary |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| Forme | Liquid |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P01730 |
| Expression | CD4 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 920 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Formule | PBS with BSA and 0.09% sodium azide; pH 7.2 |
| Alias de gène | Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen |
| Clone | SK3 (SK-3) |
| Antigène | CD4 |
CD4 Monoclonal Antibody (SK3 (SK-3)), NovaFluor™ Violet 690, eBioscience™, Invitrogen™
Mouse Monoclonal Antibody
| Applications | Flow Cytometry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | NovaFluor Violet 690 |
| Espèces cibles | Human |
| Concentration | 0.1 μg/Test |
| Primaire ou secondaire | Primary |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| Forme | Liquid |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P01730 |
| Expression | CD4 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 920 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Formule | PBS with BSA and 0.09% sodium azide; pH 7.2 |
| Alias de gène | Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen |
| Clone | SK3 (SK-3) |
| Antigène | CD4 |